StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1840
This month
50
This week
6
This year
167
Yesterday
1
Publishing Date
2024 - 04 - 09
9
2024 - 04 - 08
7
2024 - 04 - 02
7
2024 - 03 - 06
8
2024 - 03 - 05
19
2023 - 12 - 11
6
2023 - 11 - 06
7
2023 - 11 - 03
13
2023 - 10 - 03
6
2023 - 09 - 27
12
2023 - 09 - 26
6
2023 - 04 - 19
8
2023 - 04 - 18
10
2023 - 04 - 17
14
2023 - 03 - 15
11
2023 - 03 - 14
19
2023 - 02 - 09
6
2023 - 02 - 06
6
2023 - 01 - 04
6
2022 - 11 - 10
15
2022 - 10 - 05
14
2022 - 05 - 19
7
2022 - 04 - 13
9
2022 - 04 - 11
6
2022 - 04 - 08
23
2022 - 03 - 09
7
2022 - 03 - 08
30
2022 - 02 - 15
6
2022 - 01 - 18
8
2021 - 12 - 13
6
2021 - 11 - 30
6
2021 - 11 - 15
5
2021 - 11 - 12
13
2021 - 11 - 11
5
2021 - 11 - 09
10
2021 - 10 - 13
6
2021 - 10 - 12
5
2021 - 10 - 07
6
2021 - 10 - 01
21
2021 - 09 - 20
5
2021 - 09 - 14
7
2021 - 09 - 07
7
2021 - 08 - 05
5
2021 - 06 - 29
6
2021 - 06 - 11
6
2021 - 05 - 21
6
2021 - 05 - 20
8
2021 - 05 - 19
5
2021 - 04 - 19
6
2021 - 04 - 13
5
2021 - 04 - 12
13
2021 - 04 - 10
11
2021 - 04 - 09
10
2021 - 04 - 08
6
2021 - 03 - 23
5
2021 - 03 - 11
7
2021 - 03 - 10
12
2020 - 12 - 17
5
2020 - 12 - 08
6
2020 - 12 - 01
5
Sector
Commercial services
34
Communications
72
Consumer non-durables
9
Consumer services
5
Distribution services
11
Electronic technology
5
Finance
19
Health services
80
Health technology
1287
Information
1
Manufacturing
138
Mining, quarrying, and oil and gas extraction
2
N/a
33
Non-energy minerals
3
Process industries
3
Producer manufacturing
2
Professional, scientific, and technical services
64
Retail trade
4
Technology services
23
Transportation
1
Wholesale trade
3
Tags
Acquisition
738
Agreement
915
America
658
Application
1356
Approval
1348
Business
630
Cancer
1840
Collaboration
682
Conference
2329
Contract
835
Corporation
835
Covid
767
Covid-19
581
Designation
907
Disease
1190
Drug
1437
Energy
1430
Europe
736
Events
560
Fda
2712
Financial
2040
Financial results
964
For
677
Global
1747
Group
654
Growing
627
Growth
2829
Health
889
License
671
Management
602
Market
3386
Meeting
989
N/a
46060
Order
629
Partnership
554
Patent
818
Pharm-country
598
Pharmaceuticals
664
Phase 2
720
Platform
656
Positive
1228
Potential
633
Presentation
599
Program
754
Report
1750
Research
2559
Results
4590
Services
663
Solutions
712
Study
846
System
773
Technology
1171
Test
715
Therapeutics
1795
Therapy
1314
Treatment
3929
Trial
2267
Update
647
Vaccine
597
Year
1856
Entities
Abbott laboratories
9
Abbvie inc.
14
Affimed n.v.
8
Amgen inc.
18
Anixa biosciences, inc.
16
Aptevo therapeutics inc.
9
Astellas pharma inc
25
Astrazeneca plc
31
Beigene, ltd.
21
Biocept, inc.
13
Bionano genomics, inc.
8
Briacell therapeutics corp.
15
Bristol-myers squibb company
37
Coherus biosciences, inc.
13
Eli lilly and company
44
Exact sciences corporation
14
Exelixis, inc.
9
Genmab a/s
13
Genprex, inc.
14
Gilead sciences, inc.
26
Guardant health, inc.
28
Hoth therapeutics, inc.
20
Hutchison china meditech limited
10
Illumina, inc.
15
Immunitybio inc
9
Immutep limited
14
Incyte corporation
17
Iovance biotherapeutics, inc.
14
Jaguar health, inc.
19
Johnson & johnson
44
Kintara therapeutics, inc.
9
Lantern pharma inc.
13
Maia biotechnology, inc.
15
Medicenna therapeutics corp.
9
Merck & company, inc.
41
Merus n.v.
10
Mirati therapeutics, inc.
11
Myovant sciences ltd.
10
Myriad genetics, inc.
13
Novartis ag
16
Novocure limited
12
Nuvectis pharma, inc.
11
Oncolytics biotech inc.
9
Orange
72
Panbela therapeutics inc
9
Pfizer, inc.
22
Phio pharmaceuticals corp.
9
Regeneron pharmaceuticals, inc.
14
Renovorx inc
11
Sanofi
57
Seagen inc.
28
Sensei biotherapeutics inc
11
Sorrento therapeutics, inc.
9
Sutro biopharma, inc.
10
Takeda pharmaceutical company limited
13
Thermo fisher scientific inc
14
Urogen pharma ltd.
10
Veracyte, inc.
15
Viewray, inc.
12
Vincera pharma inc
9
Symbols
ABBV
14
ABT
9
ALPMF
25
ALPMY
25
AMGN
18
ANIX
16
APVO
9
AZN
31
AZNCF
10
BCTX
15
BGNE
21
BIOC
13
BMY
37
CHRS
13
EXAS
14
EXEL
9
FNCTF
72
GH
28
GILD
26
GMAB
13
GNPX
14
HCM
10
HOTH
20
IBRX
9
ILMN
15
IMMP
14
INCY
17
IOVA
14
JAGX
19
JNJ
44
KTRA
9
LLY
44
LTRN
13
MAIA
15
MDNA
9
MRK
41
MRTX
11
MRUS
10
MYGN
13
MYOV
10
NVCR
12
NVCT
11
NVS
16
NVSEF
12
ONCY
9
PBLA
9
PFE
22
PHIO
9
REGN
14
RNXT
11
SGEN
28
SNSE
11
SNY
57
SNYNF
46
STRO
10
TAK
13
TMO
14
URGN
10
VCYT
15
VRAY
12
Exchanges
Amex
29
Nasdaq
1622
Nyse
326
Crawled Date
2024 - 04 - 09
9
2024 - 04 - 08
9
2024 - 04 - 02
7
2024 - 03 - 06
7
2024 - 03 - 05
19
2023 - 12 - 11
6
2023 - 11 - 06
7
2023 - 11 - 03
13
2023 - 10 - 18
6
2023 - 10 - 03
6
2023 - 09 - 27
12
2023 - 09 - 26
6
2023 - 04 - 19
8
2023 - 04 - 18
10
2023 - 04 - 17
14
2023 - 03 - 15
12
2023 - 03 - 14
18
2023 - 02 - 09
6
2023 - 01 - 04
6
2022 - 11 - 10
15
2022 - 10 - 05
14
2022 - 05 - 19
7
2022 - 04 - 13
9
2022 - 04 - 11
6
2022 - 04 - 08
23
2022 - 03 - 09
8
2022 - 03 - 08
28
2022 - 02 - 15
6
2022 - 01 - 18
7
2021 - 12 - 13
6
2021 - 11 - 30
6
2021 - 11 - 12
13
2021 - 11 - 09
9
2021 - 10 - 13
6
2021 - 10 - 07
6
2021 - 10 - 01
21
2021 - 09 - 14
7
2021 - 09 - 07
7
2021 - 08 - 05
5
2021 - 06 - 29
6
2021 - 06 - 11
6
2021 - 05 - 21
6
2021 - 05 - 20
8
2021 - 05 - 19
5
2021 - 05 - 06
5
2021 - 04 - 19
6
2021 - 04 - 13
5
2021 - 04 - 12
12
2021 - 04 - 10
10
2021 - 04 - 09
10
2021 - 04 - 08
6
2021 - 03 - 23
5
2021 - 03 - 11
8
2021 - 03 - 10
11
2021 - 02 - 04
5
2021 - 01 - 13
5
2020 - 12 - 17
5
2020 - 12 - 15
5
2020 - 12 - 08
6
2020 - 12 - 01
12
Crawled Time
00:00
37
00:11
1
00:20
8
01:00
30
02:00
12
03:00
4
04:00
2
04:20
1
05:00
7
06:00
11
06:03
1
07:00
15
08:00
18
09:00
20
10:00
22
10:21
1
10:43
1
10:52
1
11:00
79
11:01
1
12:00
216
12:03
1
12:05
2
12:06
1
12:07
1
12:15
36
12:20
45
12:30
28
13:00
223
13:01
2
13:04
2
13:15
15
13:20
40
13:30
45
13:35
2
14:00
162
14:01
3
14:02
2
14:15
11
14:20
24
14:30
25
14:35
2
15:00
96
15:15
4
15:20
12
15:30
15
16:00
69
16:20
19
17:00
43
18:00
56
19:00
39
20:00
53
20:20
9
21:00
72
22:00
92
22:01
2
22:04
3
22:14
3
22:15
3
23:00
54
Source
adnas.com
1
immunitybio.com
1
investor.alkermes.com
3
investor.aveooncology.com
1
investors.phiopharma.com
4
investors.senseibio.com
8
ir.biolinerx.com
1
ir.chemocentryx.com
1
ir.hoththerapeutics.com
1
ir.vaccinex.com
3
jaguarhealth.gcs-web.com
12
mdxhealth.com
3
renovorx.com
7
spacfeed.com
2
www.adnas.com
1
www.affimed.com
1
www.allogene.com
2
www.biospace.com
872
www.celyad.com
2
www.fda.gov
12
www.gflenv.com
1
www.globenewswire.com
594
www.hepionpharma.com
1
www.hutch-med.com
1
www.immatics.com
2
www.immunoprecise.com
2
www.myriad.com
1
www.nanthealth.com
2
www.nantkwest.com
5
www.novocure.com
3
www.poseida.com
1
www.precisionbiosciences.com
1
www.prnewswire.com
275
www.rubiustx.com
1
www.sutrobio.com
8
www.theratech.com
1
www.vermillion.com
2
www.wexinc.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
tags :
Cancer
save search
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published:
2024-04-18
(Crawled : 13:00)
- globenewswire.com
ONCT
|
$8.97
4.3%
4.12%
4.5K
|
Health Technology
|
Email alert
Add to watchlist
onct-534
first
cancer
treatment
for
study
Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Published:
2024-04-17
(Crawled : 12:00)
- globenewswire.com
IMMP
|
$2.25
2.27%
2.22%
90K
|
Health Technology
|
-5.58%
|
O:
-6.87%
H:
0.0%
C:
0.0%
tacti-004
lung
positive
cancer
cell
for
trial
Propanc Biopharma Receives Certificate of Grant for “Composition of Proenzymes for Cancer Treatment” Patent from European Patent Office
Published:
2024-04-16
(Crawled : 15:00)
- biospace.com/
PPCB
|
$0.001
-41.86%
11M
|
Manufacturing
|
-7.14%
|
O:
0.0%
H:
14.29%
C:
-7.14%
patent
cancer
biopharma
for
grant
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published:
2024-04-16
(Crawled : 14:00)
- biospace.com/
JAGX
|
$0.158
-10.79%
-12.09%
30M
|
Health Technology
|
51.52%
|
O:
26.26%
H:
73.2%
C:
18.87%
health
cancer
care
for
commercial
BostonGene and Saga University Announce Collaboration to Uncover Biomarkers for Improved Immunotherapy Response in Lung Cancer Patients
Published:
2024-04-16
(Crawled : 13:00)
- biospace.com/
NIPNF
|
$68.91
-52.94%
120
|
Technology Services
|
Email alert
Add to watchlist
lung
cancer
immunotherapy
for
collaboration
saga
response
biomarkers
UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Published:
2024-04-15
(Crawled : 13:00)
- biospace.com/
URGN
|
$13.78
-3.37%
-3.48%
390K
|
Health Technology
|
-5.1%
|
O:
1.46%
H:
1.17%
C:
-1.44%
ugn-103
fda
drug
bladder
cancer
for
application
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
Published:
2024-04-11
(Crawled : 13:00)
- globenewswire.com
CADL
|
$5.17
-5.31%
-5.61%
520K
|
|
7.06%
|
O:
25.49%
H:
23.75%
C:
13.75%
can-2409
fda
drug
cancer
pancreatic
treatment
designation
for
therapeutics
Provectus Biopharmaceuticals Announces Presentation of Cancer Immunotherapy PV-10 Poster for HNSCC at AACR 2024 Annual Meeting
Published:
2024-04-11
(Crawled : 12:00)
- globenewswire.com
PVCT
4
|
$0.195
-15.0%
56K
|
Manufacturing
|
11.96%
|
O:
0.0%
H:
17.21%
C:
7.19%
pv-10
presentation
cancer
immunotherapy
for
meeting
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published:
2024-04-11
(Crawled : 12:00)
- biospace.com/
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
1.85%
|
O:
1.85%
H:
0.0%
C:
0.0%
biotech
fda
breast
cancer
for
meeting
trial
submission
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.57%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$34.78
1.43%
1.41%
940K
|
Health Technology
|
-7.45%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
Published:
2024-04-10
(Crawled : 12:00)
- globenewswire.com
MNPR
|
$0.636
-6.19%
-6.6%
33K
|
Health Technology
|
15.71%
|
O:
4.79%
H:
5.3%
C:
3.41%
mnpr-101
cancer
for
trial
advanced
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
Published:
2024-04-10
(Crawled : 12:00)
- globenewswire.com
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
-3.83%
|
O:
-3.83%
H:
0.0%
C:
0.0%
breast
cancer
preclinical
for
Apollomics Presents Vebreltinib Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published:
2024-04-10
(Crawled : 11:00)
- globenewswire.com
APLM
|
$0.472
-7.45%
-8.05%
170K
|
n/a
|
-4.91%
|
O:
-2.99%
H:
6.9%
C:
0.0%
association
cancer
research
for
meeting
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published:
2024-04-10
(Crawled : 11:00)
- globenewswire.com
MDNAF
|
$1.24
-17.54%
67K
|
n/a
|
16.51%
|
O:
18.35%
H:
13.64%
C:
12.4%
mdna11
association
cancer
ongoing
expansion
research
for
meeting
results
study
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published:
2024-04-09
(Crawled : 21:00)
- globenewswire.com
MDNAF
|
$1.24
-17.54%
67K
|
n/a
|
16.51%
|
O:
18.35%
H:
13.64%
C:
12.4%
mdna11
association
cancer
ongoing
expansion
research
for
meeting
results
study
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
Published:
2024-04-09
(Crawled : 20:00)
- globenewswire.com
MURA
|
$3.55
-0.56%
-0.56%
240K
|
|
-14.39%
|
O:
-1.2%
H:
1.94%
C:
0.0%
il-18
association
cancer
research
preclinical
for
meeting
il-12
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
Published:
2024-04-09
(Crawled : 20:00)
- globenewswire.com
STTK
|
$9.58
-5.43%
-5.74%
420K
|
Health Technology
|
11.33%
|
O:
-1.11%
H:
9.78%
C:
9.66%
association
presentation
cancer
research
preclinical
for
meeting
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published:
2024-04-09
(Crawled : 16:00)
- globenewswire.com
CMPX
|
$1.48
-0.67%
-0.68%
230K
|
Professional, Scientific, and T...
|
-7.65%
|
O:
2.06%
H:
0.0%
C:
0.0%
association
tumors
cancer
research
for
meeting
therapeutics
negative
Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published:
2024-04-09
(Crawled : 16:00)
- globenewswire.com
MDNAF
|
$1.24
-17.54%
67K
|
n/a
|
-3.05%
|
O:
-3.82%
H:
0.0%
C:
-13.49%
mdna113
association
cancer
research
preclinical
for
meeting
Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published:
2024-04-09
(Crawled : 13:30)
- biospace.com/
MTEM
|
$1.455
-2.02%
-2.06%
13K
|
Health Technology
|
-19.46%
|
O:
9.73%
H:
0.49%
C:
-8.87%
mt-6402
association
tumors
cancer
research
for
meeting
molecular
study
← Previous
1
2
3
4
5
6
7
8
9
…
91
92
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.